| Metric | FY 2025↕ | FY 2024↕ | FY 2015↕ |
|---|---|---|---|
| Revenue | $2.6B | $2.1B | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | — | — | — |
| Operating Income | $-0.1B | $0.2B | $0.1B |
| Net Income | $-0.2B | $1.0B | $-0.1B |
| EPS (Basic) | $-4.79 | $18.40 | $-0.48 |
| EPS (Diluted) | $-4.79 | $17.67 | $-0.48 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2015↕ |
|---|---|---|---|
| Total Assets | $10.9B | $6.1B | $12.8B |
| Current Assets | $1.3B | $1.0B | $2.8B |
| Cash & Equivalents | $0.7B | $0.3B | $0.1B |
| Total Liabilities | $9.8B | $4.7B | — |
| Current Liabilities | $1.1B | $0.5B | $2.1B |
| Stockholders' Equity | $1.1B | $1.4B | $4.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2015↕ |
|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.3B | $0.8B |
| Investing Cash Flow | $-4.0B | $1.2B | $-0.9B |
| Capital Expenditures | $0.1B | $0.1B | $0.5B |
| Financing Cash Flow | $3.7B | $-2.0B | $-0.1B |